• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ic类抗心律失常药物治疗期间心房扑动患者的晕厥

Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.

作者信息

Kawabata M, Hirao K, Horikawa T, Suzuki K, Motokawa K, Suzuki F, Azegami K, Hiejima K

机构信息

First Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

J Electrocardiol. 2001 Jan;34(1):65-72. doi: 10.1054/jelc.2001.22034.

DOI:10.1054/jelc.2001.22034
PMID:11239374
Abstract

We describe 2 atrial flutter (AFL) patients with syncope during treatment with class Ic antiarrhythmic drugs. During the syncope, 1:1 atrioventricular (AV) conduction during AFL preceded a wide QRS tachycardia. The class Ic drugs, flecainide and pilsicainide, slowed the atrial rate, resulting in AFL with 1:1 AV conduction, and the width of the QRS complexes became wider during the tachycardia. Syncope was abolished after successful radiofrequency catheter ablation of the AFL. These potential proarrhythmic effects of the class Ic drugs should be taken into account in AFL patients, and concomitant use of beta-blocking agents would be critical to prevent proarrhythmias.

摘要

我们描述了2例在使用Ic类抗心律失常药物治疗期间出现晕厥的心房扑动(AFL)患者。在晕厥期间,AFL时的1:1房室(AV)传导先于宽QRS心动过速出现。Ic类药物氟卡尼和吡西卡尼减慢了心房率,导致AFL伴1:1 AV传导,且心动过速期间QRS波群宽度变宽。成功进行AFL的射频导管消融术后晕厥消失。Ic类药物的这些潜在促心律失常作用在AFL患者中应予以考虑,同时使用β受体阻滞剂对于预防心律失常至关重要。

相似文献

1
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.Ic类抗心律失常药物治疗期间心房扑动患者的晕厥
J Electrocardiol. 2001 Jan;34(1):65-72. doi: 10.1054/jelc.2001.22034.
2
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.具有1:1房室传导的心房扑动患者的临床和电生理特征
Europace. 2008 Mar;10(3):284-8. doi: 10.1093/europace/eun012. Epub 2008 Feb 7.
3
Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.吡西卡尼诱发的心房扑动患者的药物与消融联合治疗的长期疗效
Clin Cardiol. 2005 Jul;28(7):338-42. doi: 10.1002/clc.4960280707.
4
Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.纯钠通道阻滞剂吡西卡尼和氟卡尼对心房肌电生理作用的差异。
Cardiovasc Drugs Ther. 2004 Jul;18(4):295-303. doi: 10.1023/B:CARD.0000041249.35724.da.
5
Rate-dependent and site-specific conduction block at the posterior right atrium and drug effects evaluated using a noncontact mapping system in patients with typical atrial flutter.使用非接触式标测系统评估典型心房扑动患者右心房后部的速率依赖性和部位特异性传导阻滞及药物作用。
J Cardiovasc Electrophysiol. 2012 Aug;23(8):827-34. doi: 10.1111/j.1540-8167.2012.02313.x. Epub 2012 Mar 27.
6
Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia.
J Cardiovasc Electrophysiol. 1998 Aug;9(8):855-8. doi: 10.1111/j.1540-8167.1998.tb00125.x.
7
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.I类C型抗心律失常药物诱发的右胸前导联ST段抬高:对Brugada综合征机制的深入了解
J Cardiovasc Electrophysiol. 1999 Feb;10(2):214-8. doi: 10.1111/j.1540-8167.1999.tb00662.x.
8
Proarrhythmic Antiarrhythmic.促心律失常的抗心律失常药物
Tex Heart Inst J. 2016 Dec 1;43(6):507-508. doi: 10.14503/THIJ-16-6088. eCollection 2016 Dec.
9
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].[在I类抗心律失常药物治疗期间出现宽QRS波群的室上性心动过速。诊断和治疗意义]
Arch Mal Coeur Vaiss. 1995 Dec;88(12):1869-74.
10
Wide complex tachycardia in the presence of class I antiarrhythmic agents: a diagnostic challenge.在使用I类抗心律失常药物情况下出现的宽QRS波心动过速:一项诊断挑战。
Ann Noninvasive Electrocardiol. 2014 May;19(3):289-92. doi: 10.1111/anec.12099. Epub 2013 Sep 24.

引用本文的文献

1
Demographic trends in mortality with older population due to atrial fibrillation and flutter from 1999-2020.1999年至2020年老年人口因心房颤动和扑动导致的死亡率的人口统计学趋势。
World J Cardiol. 2025 Jan 26;17(1):99933. doi: 10.4330/wjc.v17.i1.99933.
2
Endurance Sports and Atrial Fibrillation: A Puzzling Conundrum.耐力运动与心房颤动:一个令人困惑的难题。
J Clin Med. 2024 Dec 17;13(24):7691. doi: 10.3390/jcm13247691.
3
Diagnosis and Management of 1:1 Atrial Flutter in the Setting of Aortic Valve Endocarditis and Embolic Stroke.
主动脉瓣心内膜炎和栓塞性卒中背景下1:1房扑的诊断与管理
Cureus. 2020 Jun 21;12(6):e8739. doi: 10.7759/cureus.8739.
4
Atrial Fibrillation (AF) in Endurance Athletes: a Complicated Affair.耐力运动员的心房颤动:一件复杂的事情。
Curr Treat Options Cardiovasc Med. 2018 Oct 26;20(12):98. doi: 10.1007/s11936-018-0697-9.
5
Endurance Sport Practice and Atrial Fibrillation.耐力运动训练与心房颤动
J Atr Fibrillation. 2010 Oct 22;3(3):288. doi: 10.4022/jafib.288. eCollection 2010 Oct-Nov.
6
Arrhythmias in the athlete.运动员的心律失常
Herzschrittmacherther Elektrophysiol. 2012 Jun;23(2):76-81. doi: 10.1007/s00399-012-0182-1.
7
Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.吡西卡尼诱发的心房扑动患者的药物与消融联合治疗的长期疗效
Clin Cardiol. 2005 Jul;28(7):338-42. doi: 10.1002/clc.4960280707.